Skip to main content
Caplight Logo









ICM Co., Ltd.

ICM Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttp://icm-bio.com/

Last Round

Growth Equity

May 25, 2021

Total Funding Raised

$45.22M

Company Overview

ICM Co., Ltd. is a biotechnology company that develops recombinant adeno-associated virus (rAAV) gene therapies for incurable degenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

adeno-associated virusAAVgene therapybiotechvector engineeringdrug discoveryosteoarthritis treatmentretinal degenerationgene deliverybiopharmaclinical trialslicensing agreementdegenerative diseaseveterinary medicinebiologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ICM Co., Ltd. Comparables

Compare ICM Co., Ltd. with similar companies based on industry and business-model similarity.

ICM Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genascence Corporation
83%
Coave Therapeutics
81%
MeiraGTx Holdings
77%

ICM Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 25, 2021
Series AJun 1, 2016

ICM Co., Ltd. Investors

Notable investors and investment history

ICM Co., Ltd. investors
InvestorRounds
LB InvestmentGrowth Equity
IMM InvestmentGrowth Equity, Series B
Atinum InvestmentGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 25, 2021

    $18.35M round led by Atinum Investment, IMM Investment, and LB Investment.

ICM Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

ICM Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ICM Co., Ltd.'s valuation, stock price, and market status.

Is ICM Co., Ltd. a public or private company?

ICM Co., Ltd. is a private company.

What is the current stock price of ICM Co., Ltd.?

ICM Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is ICM Co., Ltd. worth (valuation)?

Valuation information for ICM Co., Ltd. is not publicly available.

Can I buy ICM Co., Ltd. stock?

ICM Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ICM Co., Ltd.'s last funding round?

ICM Co., Ltd.'s most recent funding round was Growth Equity on May 25, 2021.

Who are the main investors in ICM Co., Ltd.?

Key investors in ICM Co., Ltd. include LB Investment, IMM Investment, Atinum Investment.

Will ICM Co., Ltd. IPO soon?

No public IPO plans have been announced for ICM Co., Ltd..

How can I track ICM Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ICM Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Year Founded2012
Last FundingMay 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?